[BIC-announce] FW: Killam Lecture - TODAY - Human Embryonic Stem Cell Derviates for the Treatment of Spinal Cord Injury and Disease

[Jennifer Chew, Ms.]

PLEASE DISCARD IF THIS IS A DUPLICATE.  THANK YOU.  JENNIFER

Jennifer Chew
McConnell Brain Imaging Centre
MNI - WB317
3801 University Street
Montreal, Qc  H3A 2B4
Telephone:  514-398-8554
Fax:  514-398-2975



________________________________
From: MNISTAFF - Montreal Neurological Institute Staff [mailto:MNISTAFF at LISTS.MCGILL.CA] On Behalf Of Enza Ferracane, Ms.
Sent: Tuesday, February 02, 2010 8:47 AM
To: MNISTAFF at LISTS.MCGILL.CA
Subject: Killam Lecture - TODAY

**REMINDER**

Killam Lecture

Speaker:  Hans Keirstead, PhD,
Department of Anatomy & Neurobiology
University of California, Irvine

Title:  Human Embryonic Stem Cell Derviates for the Treatment of Spinal Cord Injury and Disease

Time:  4:00 PM

Date: TODAY

Place:  de Grandpre Communications Centre


Dr. Hans Keirstead is Associate Professor of Anatomy and Neurobiology and Co-Director of the Sue and Bill Gross Stem Cell Research Center at the UC Irvine Reeve-Irvine Research Center. In 2004, Hans Keirstead led his team of researchers at UC Irvine to successfully develop a human embryonic stem cell derived treatment for acute spinal cord injuries in rats. That treatment was recently approved by FDA for clinical trials in humans with acute spinal cord injuries. The trial, which will be carried out by Geron Corporation, marks the first human embryonic stem cell trial ever approved in the U.S.


Enza Ferracane
Montreal Neurological Institute
3801 University
Montreal, Quebec  H3A 2B4
Director's Office, Rm 636
Tel: (514) 398-1903
Fax:  (514) 398-8248
Email: enza.ferracane at mcgill.ca<mailto:enza.ferracane at mcgill.ca>

-------------- next part --------------
An HTML attachment was scrubbed...
URL: http://www2.bic.mni.mcgill.ca/pipermail/bic-announce/attachments/20100202/983ba837/attachment.htm